Teclistamab Toxicity and Efficacy Outcomes in MM Above 70 [ASH 2023] Multiple Myeloma 2 Mins Read41 At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina, discussed a multicenter study focusing…
